Health Condition 1: null- Traumatic Brain injury
Conditions
Interventions
None listed
Sponsors
Department of biotechnology applied for
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for observational study 1. Clinical diagnosis of TBI 2. Clinical indication for CT scan Inclusion criteria for core data study 1. Presentation within 24 hours of injury 2. Informed consent obtained according to local and national requirements
Exclusion criteria
Exclusion criteria: Severe pre-existing neurological disorder that would confound outcome assessments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢To improve characterization and classification of TBI in Europe and India , with inclusion of emerging technologies. â?¢ To identify the most effective clinical care and to provide high quality evidence in support of treatment recommendations and guidelines. Timepoint: â?¢ Outcomes assessment ( Functional GOSE, Health related quality of life, Neuropsychological tests) will be assessed at 3/6/12/24months follow up period. | — |
Secondary
| Measure | Time frame |
|---|---|
| - To collect high quality clinical and epidemiological data with repositories for neuro-imaging, DNA, and serum from patients with TBI.- To refine and improve outcome assessment and develop health utility indices for TBI. - To develop multidimensional approaches to characterisation and prediction of TBI. Timepoint: 6 months and 2 years | — |
Countries
Australia, Austria, Belgium, China, Denmark, Finland, France, Germany, Italy, Netherlands, New Zealand, Norway, Slovakia, Sweden, United Kingdom, United States of America
Contacts
Public ContactDr Deepak Gupta
All India Institute of Medical Sciences
Outcome results
None listed